Literature DB >> 32785447

Risk factors for constant glycemic variability in pregnant women: a case-control study.

Grasiela Martins Barros1, Lyvia da Silva Figueiredo1, Priscilla Alfradique de Souza2, Beatriz Paiva E Silva de Souza1, Helen Campos Ferreira1, Ana Carla Dantas Cavalcanti1.   

Abstract

OBJECTIVE: to identify the factors associated with pregnancy that influence constant glycemic variability.
METHOD: a case-control study with random sampling. The medical records of 417 pregnant women were divided into case group (200 pregnant women with constant glycemic variability) and control group (217 pregnant women without constant glycemic variability). Data were collected from 2009 to 2015.
RESULTS: pregnant women aged 25 years and over, with family history of diabetes mellitus, with systemic arterial hypertension, overweightness or obesity, sedentarism and polycystic ovarian syndrome are more likely to present changes in blood glucose.
CONCLUSION: The study demonstrated that risk factors associated with pregnancy increase the risk of constant glycemic variability. The findings will allow reassessment of the interventions during pregnancy, providing an increase in nursing care quality.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32785447     DOI: 10.1590/0034-7167-2018-0983

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Glycemic Control Trajectories and Risk of Perinatal Complications Among Individuals With Gestational Diabetes.

Authors:  Rana F Chehab; Assiamira Ferrara; Mara B Greenberg; Amanda L Ngo; Juanran Feng; Yeyi Zhu
Journal:  JAMA Netw Open       Date:  2022-09-01

2.  Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring.

Authors:  Martina Gáborová; Viera Doničová; Ivana Bačová; Mária Pallayová; Martin Bona; Igor Peregrim; Soňa Grešová; Judita Štimmelová; Barbora Dzugasová; Lenka Šalamonová Blichová; Viliam Donič
Journal:  Int J Environ Res Public Health       Date:  2021-03-25       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.